Search

Displaying results 5671 - 5680 of 9132 in total
  1. Drug

    Equilenin

    go.drugbank.com/drugs/DB03515
    Experimental

    Equilenin is an estrogenic steroid produced by horses. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the urine of pregnant mares.

  2. Drug

    MRx-4DP0004

    go.drugbank.com/drugs/DB15751
    Investigational

    MRx-4DP0004 is a lyophilised formulation of the Bifidobacterium breve strain of commensal bacteria. It is a live biotherapeutic derived from the microbiota of a healthy human infant.

  3. Drug

    Batroxobin

    go.drugbank.com/drugs/DB09005
    Investigational

    Batroxobin is a defibrinogenating hemostatic agent derived from the venom of a pit viper, Bothrops atrox moojeni. … Batroxobin will also bind fibrinogen in a manner different than thrombin and with a higher affinity.

    Categories: Venombin A
  4. Drug

    Poloxalene

    go.drugbank.com/drugs/DB11451
    InvestigationalVet approved

    Ethylene oxide/propylene oxide copolymer is used as a food additive. It belongs to the family of Epoxides. … These are compounds containing a cyclic ether with three ring atoms (one oxygen and two carbon atoms).

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Sulfaquinoxaline

    go.drugbank.com/drugs/DB11464
    ExperimentalVet approved

    Sulfaquinoxaline is a veterinary medicine which can be given to cattle and sheep to treat coccidiosis.It is available in Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K as

  6. Drug

    Rineterkib

    go.drugbank.com/drugs/DB17560
    Investigational

    Rineterkib is an inhibitor of extracellular signal-regulated kinase (ERK) being investigated in NCT04097821 (A Randomized, Open-label, Phase I/II Open Platform Study Evaluating Safety and Efficacy of Novel

  7. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications.

  8. Drug

    Isoxepac

    go.drugbank.com/drugs/DB19733
    Experimental

    Isoxepac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Isoxepac is a anti-inflammatory agent, ibufenac derivative. … Isoxepac has a monoisotopic molecular weight of 268.07 Da.

  9. Drug

    Lexofenac

    go.drugbank.com/drugs/DB19789
    Experimental

    Lexofenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Lexofenac is a anti-inflammatory agent, ibufenac derivative. … Lexofenac has a monoisotopic molecular weight of 230.09 Da.

  10. Drug

    Eltenac

    go.drugbank.com/drugs/DB20457
    Experimental

    Eltenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Eltenac is a anti-inflammatory agent, ibufenac derivative. … Eltenac has a monoisotopic molecular weight of 300.97 Da.